scholarly journals The Prescribing Patterns of Antipsychotic Drugs and Antiparkinsonian Drugs in Elderly Patients with Dementia

2020 ◽  
Vol 30 (2) ◽  
pp. 81-86
Author(s):  
Soo Mi Yoon ◽  
Sungwon Lee ◽  
Ji-Eun Chang ◽  
Young Sook Lee ◽  
Kiyon Rhew
Keyword(s):  
Elderly Patients ◽  
Antipsychotic Drugs ◽  
Prescribing Patterns ◽  
Antiparkinsonian Drugs

1808 – The use of antipsychotic drugs in elderly patients with dementia

2013 ◽  
Vol 28 ◽  
pp. 1
Author(s):  
H. Ben Ammar ◽  
A. Bel Arbi ◽  
L. Robbana ◽  
O. Moula ◽  
A. Bouasker ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Antipsychotic Drugs

Antipsychotic Drugs and Cerebrovascular Events in Elderly Patients with Dementia: A Systematic Review

2008 ◽  
Vol 8 (8) ◽  
pp. 776-783 ◽  
Author(s):  
Sara Mazzucco ◽  
Andrea Cipriani ◽  
Corrado Barbui ◽  
Salvatore Monaco
Keyword(s):  
Systematic Review ◽  
Elderly Patients ◽  
Antipsychotic Drugs ◽  
Cerebrovascular Events

Co-prescribing Patterns of Contraindicated Drugs for the Elderly Patients in Busan.

2008 ◽  
Vol 30 (1) ◽  
pp. 128-136
Author(s):  
Nam Kyong Choi ◽  
Sun Young Jung ◽  
Byung Joo Park
Keyword(s):  
Elderly Patients ◽  
The Elderly ◽  
Prescribing Patterns

scholarly journals Analysis of antidepressant prescribing tendencies in Lithuania in 2003–2004

Medicina ◽  
2007 ◽  
Vol 43 (5) ◽  
pp. 412
Author(s):  
Mantas Jakimavičius ◽  
Audrius Sveikata ◽  
Paulius Vainauskas ◽  
Rimas Jankūnas ◽  
Loreta Mikučionytė ◽  
...  
Keyword(s):  
Elderly Patients ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Developed Countries ◽  
Serotonin Reuptake Inhibitors ◽  
Prescribing Patterns ◽  
Selective Serotonin ◽  
Duration Of Treatment ◽  
Defined Daily Doses ◽  
Antidepressant Use

Depression is one of the leading causes of disability worldwide, affecting 121 million people in whole world. In many developed countries, the number of prescriptions for antidepressants increased steeply during the 1990s. The objective of the present study was to evaluate the antidepressant prescribing patterns in all regions of Lithuania during 2003–2004, to analyze the use within different antidepressant groups, and to examine trends in age- and gender-specific antidepressant use. Antidepressants were classified into three groups according to Anatomic Therapeutic Chemical (ATC) Classification specifying the defined daily doses. The results of our study show an increase in the use of reimbursed antidepressants except tricyclic in 2004 when compared to 2003. Increase in the use of selective serotonin reuptake inhibitors and other nontricyclic antidepressants is probably related to their better tolerability, improved risk-benefit ratio, and less toxicity in overdose. There was no increase in the percentage of consumed selective serotonin reuptake inhibitors in elderly patients when compared with younger ones, despite elderly patients are most likely to benefit from reduced sedation, less antimuscarinic and less cardiac toxicity of selective serotonin reuptake inhibitors. The prevalence of the antidepressant use is the highest among middle-aged people (40–59 years), while the young (under 20) and elderly (older than 70) patients receive mostly selective serotonin reuptake inhibitors. Additional studies should be carried out in order to assess drug-prescribing patterns in accordance with the guidelines of depression treatment in Lithuania considering diagnosis, dosage, and duration of treatment.

Topical Corticosteroid Prescribing Patterns following Changes in Drug Benefit Status

2003 ◽  
Vol 37 (6) ◽  
pp. 787-793 ◽  
Author(s):  
Chole A Campbell ◽  
Charmaine A Cooke ◽  
Swarna DS Weerasinghe ◽  
Ingrid S Sketris ◽  
Pam R McLean-Veysey ◽  
...  
Keyword(s):  
Nova Scotia ◽  
Elderly Patients ◽  
Topical Corticosteroid ◽  
Patient Outcomes ◽  
Prescribing Patterns ◽  
Drug Benefit ◽  
Topical Product ◽  
Increasing Trend ◽  
Increasing Trends ◽  
Program Benefit

OBJECTIVE: To examine changes in prescribing patterns for topical corticosteroid products dispensed to elderly patients in Nova Scotia, Canada, after all but 2 combination topical corticosteroid products were removed from the Nova Scotia Seniors' Pharmacare Program benefit list. METHODS: Administrative prescription claims from the Nova Scotia Seniors' Pharmacare Program were used to identify the number and costs of topical corticosteroid, antifungal, antibiotic, and combination corticosteroid products dispensed. Time-series analysis was used to compare the periods before (April 1, 1999–March 31, 2000) and after (April 1, 2000–March 31, 2001) the delisting. RESULTS: In 1999–2000, 26 031 of 103 400 eligible elderly patients (25%) and in 2000–2001, 22 837 of 95 550 eligible elderly (24%) received a prescription for a defined topical product. Nova Scotia Seniors' Pharmacare Program expenditures for all topical products decreased from $11.88 to $10.60 (CND) per beneficiary per year (11%) after the policy revision. Topical combination products decreased from 18% of all topical products dispensed to 14%, while the percentage of potent corticosteroid products dispensed increased from 24% to 27% over the study period. Pre- and post-policy time–trend analysis showed statistically significant increasing trends in cost per beneficiary for all topical products and potent corticosteroid products. Combination corticosteroid products showed no change in trends for costs per beneficiary before, and a slight increasing trend after, the policy revision. CONCLUSIONS: Prescribing of topical corticosteroid combination products in Nova Scotia decreased following the formulary revision. There was an increase in potent topical corticosteroid prescribing. Future study involving evaluation of patient outcomes would be useful.

scholarly journals Influencing Factors of Hospital-Acquired Pneumonia Infection in the Middle-Aged and Elderly Patients With Schizophrenia

2021 ◽  
Vol 12 ◽  
Author(s):  
Mi Yang ◽  
Qiwen Li ◽  
Chunzhi Wang ◽  
Li Li ◽  
Min Xu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Elderly Patients ◽  
Infection Rate ◽  
Large Scale ◽  
Antipsychotic Drugs ◽  
Personal Characteristics ◽  
Middle Aged ◽  
Chi Square ◽  
Hospital Acquired Pneumonia ◽  
Hospital Acquired

Introduction: Pneumonia is an important cause of death in patients with schizophrenia. It is critical to understand the risk factors of hospital-acquired pneumonia (HAP) and determine prevention strategies to reduce HAP. The aim of this study is to elucidate the risk factors for HAP in the middle-aged and elderly hospitalized patients with schizophrenia.Methods: We retrospectively reviewed the medical records of 2,617 the middle-aged and elderly patients (age ≥ 50) with schizophrenia who were admitted for the first time to a large-scale psychiatric hospital between 2016 and 2020. The factors related to the incidence of HAP in patients were analyzed, including personal characteristics, antipsychotics, and non-antipsychotics.Results: The HAP infection rate of hospitalized the middle-aged and elderly patients with schizophrenia was 7.8%. Chi-square analyses showed that older age, male, and ≥60 days of hospitalization were risk factors for HAP infection (χ2 = 94.272, p < 0.001; χ2 = 22.110, p < 0.001; χ2 = 8.402, p = 0.004). Multivariate logistic regression showed that quetiapine, clozapine, and olanzapine significantly increased the incidence of HAP (OR = 1.56, 95% CI = 1.05–2.32, p = 0.029; OR = 1.81, 95% CI = 1.26–2.60, p = 0.001; OR = 1.68, 95% CI = 1.16–2.42, p = 0.006). Antipsychotic drugs combined with aceglutamide had an effect on HAP (OR = 2.19, 95% CI = 1.38–3.47, p = 0.001).Conclusion: The high HAP infection rate in hospitalized the middle-aged and elderly patients with schizophrenia may be related to the increase of age and the use of antipsychotic drugs. The types and dosages of antipsychotic drugs should be minimized while paying attention to the mental symptoms of patients.

Sign in / Sign up

Export Citation Format

Share Document